Jonathan McNeill
Insider Reports History
- Location
- Waltham, MA
- Signature
- /s/ Barbara Bispham, as attorney-in-fact for Jonathan McNeill
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Jonathan McNeill:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Dyne Therapeutics, Inc. | Chief Business Officer | Common Stock | 132,106 | $6,076,876 | $46.00 | 19 Aug 2024 | Direct |
| CRESCENT BIOPHARMA, INC. | President and COO | Ordinary Shares | 159,707 | $2,408,381 | $15.08 | 15 Dec 2025 | Direct |
| CRESCENT BIOPHARMA, INC. | President and COO | Stock Option (Right to Buy) | 78,029 | 15 Dec 2025 | Direct | ||
| Dyne Therapeutics, Inc. | Chief Business Officer | Stock option (right to buy) | 0 | 11 Mar 2024 | Direct |
Insider Reports Filed by Jonathan McNeill
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GLYC | CRESCENT BIOPHARMA, INC. | 15 Dec 2025 | 3 | $0 | 4 | President and COO | 17 Dec 2025, 16:43 |
| GLYC | CRESCENT BIOPHARMA, INC. | 08 Dec 2025 | 1 | $0 | 4 | President and COO | 10 Dec 2025, 16:37 |
| GLYC | GLYCOMIMETICS INC | 13 Jun 2025 | 0 | $0 | 3 | Chief Operating Officer and President. Exhibit 24 - Power of Attorney | 23 Jun 2025, 18:27 |
| DYN | Dyne Therapeutics, Inc. | 19 Aug 2024 | 2 | -$122,054 | 4 | Chief Business Officer | 20 Aug 2024, 16:27 |
| DYN | Dyne Therapeutics, Inc. | 11 Jun 2024 | 1 | -$57,133 | 4 | Chief Business Officer | 11 Jun 2024, 19:34 |
| DYN | Dyne Therapeutics, Inc. | 16 May 2024 | 2 | -$78,420 | 4 | Chief Business Officer | 17 May 2024, 21:03 |
| DYN | Dyne Therapeutics, Inc. | 08 Mar 2024 | 11 | -$2,264,023 | 4 | Chief Business Officer | 13 Mar 2024, 06:04 |
| DYN | Dyne Therapeutics, Inc. | 07 Mar 2024 | 1 | -$62,919 | 4 | Chief Business Officer | 11 Mar 2024, 21:50 |
| DYN | Dyne Therapeutics, Inc. | 29 Feb 2024 | 8 | -$791,040 | 4 | Chief Business Officer | 01 Mar 2024, 21:37 |
| DYN | Dyne Therapeutics, Inc. | 26 Jan 2024 | 4 | -$475,910 | 4 | Chief Business Officer | 26 Jan 2024, 19:48 |
| DYN | Dyne Therapeutics, Inc. | 02 Jan 2024 | 8 | -$514,594 | 4 | Chief Business Officer | 04 Jan 2024, 21:47 |
| DYN | Dyne Therapeutics, Inc. | 11 Dec 2023 | 1 | -$13,346 | 4 | Chief Business Officer | 12 Dec 2023, 17:34 |
| DYN | Dyne Therapeutics, Inc. | 15 Nov 2023 | 2 | $0 | 4 | Chief Business Officer | 16 Nov 2023, 16:34 |
| DYN | Dyne Therapeutics, Inc. | 18 Sep 2023 | 1 | -$11,866 | 4 | Chief Business Officer | 20 Sep 2023, 16:49 |
| DYN | Dyne Therapeutics, Inc. | 12 Sep 2023 | 1 | -$13,179 | 4 | Chief Business Officer | 13 Sep 2023, 19:53 |
| DYN | Dyne Therapeutics, Inc. | 11 Jul 2023 | 1 | $0 | 4 | Chief Business Officer | 04 Apr 2024, 21:06 |
| DYN | Dyne Therapeutics, Inc. | 12 Jun 2023 | 2 | -$28,649 | 4 | Senior Vice President of Business Development | 14 Jun 2023, 18:40 |
| DYN | Dyne Therapeutics, Inc. | 13 Mar 2023 | 2 | -$29,116 | 4 | Senior Vice President of Business Development | 15 Mar 2023, 17:50 |
| DYN | Dyne Therapeutics, Inc. | 18 Jan 2023 | 3 | -$133,000 | 4 | Senior Vice President of Business Development | 23 Jan 2023, 07:27 |
| DYN | Dyne Therapeutics, Inc. | 09 Jan 2023 | 1 | -$348,836 | 4 | Senior Vice President of Business Development | 11 Jan 2023, 15:56 |
| DYN | Dyne Therapeutics, Inc. | 09 Dec 2022 | 3 | -$5,131 | 4 | Senior Vice President of Business Development | 13 Dec 2022, 16:05 |
| DYN | Dyne Therapeutics, Inc. | 20 Sep 2022 | 1 | -$17,070 | 4 | Senior Vice President of Business Development | 21 Sep 2022, 16:08 |
| DYN | Dyne Therapeutics, Inc. | 15 Sep 2022 | 1 | -$6,941 | 4 | Senior Vice President of Business Development | 15 Sep 2022, 17:27 |
| DYN | Dyne Therapeutics, Inc. | 05 Jul 2022 | 1 | $0 | 4 | Senior Vice President of Business Development | 06 Jul 2022, 18:21 |
| DYN | Dyne Therapeutics, Inc. | 14 Jun 2022 | 1 | -$2,495 | 4 | Senior Vice President of Business Development | 15 Jun 2022, 20:04 |
| DYN | Dyne Therapeutics, Inc. | 11 Mar 2022 | 1 | -$4,199 | 4 | Senior Vice President of Business Development | 14 Mar 2022, 17:09 |
| DYN | Dyne Therapeutics, Inc. | 10 Dec 2021 | 2 | $0 | 4 | Senior Vice President of Business Development | 14 Dec 2021, 15:22 |
| DYN | Dyne Therapeutics, Inc. | 20 Sep 2021 | 2 | -$20,252 | 4 | Senior Vice President of Business Development | 22 Sep 2021, 20:02 |
| DYN | Dyne Therapeutics, Inc. | 10 Jul 2021 | 1 | $0 | 4 | Senior Vice President of Business Development | 13 Jul 2021, 16:22 |